BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27338590)

  • 1. Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy.
    Hori M; Someya M; Matsumoto Y; Nakata K; Kitagawa M; Hasegawa T; Tsuchiya T; Fukushima Y; Gocho T; Sato Y; Ohnuma H; Kato J; Sugita S; Hasegawa T; Sakata KI
    Med Mol Morphol; 2017 Mar; 50(1):25-33. PubMed ID: 27338590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Ku86 and XRCC4 expression in uterine cervical cancer on the response to preoperative radiotherapy.
    Takada Y; Someya M; Matsumoto Y; Satoh M; Nakata K; Hori M; Saito M; Hirokawa N; Tateoka K; Teramoto M; Saito T; Hasegawa T; Sakata KI
    Med Mol Morphol; 2016 Dec; 49(4):210-216. PubMed ID: 26867665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-PKcs expression predicts response to radiotherapy in prostate cancer.
    Bouchaert P; Guerif S; Debiais C; Irani J; Fromont G
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1179-85. PubMed ID: 22494583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonhomologous end joining repair pathway molecules as predictive biomarkers for patients with oral squamous cell carcinoma.
    Joshi JS; Vora HH; Ghosh NR; Tankshali RN; Jetly DH; Trivedi TI
    J Cancer Res Ther; 2021; 17(4):1031-1038. PubMed ID: 34528560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells].
    Zhuang L; Yu SY; Huang XY; Cao Y; Xiong HH
    Ai Zheng; 2007 Jul; 26(7):724-9. PubMed ID: 17626748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy.
    Friesland S; Kanter-Lewensohn L; Tell R; Munck-Wikland E; Lewensohn R; Nilsson A
    Head Neck; 2003 Apr; 25(4):313-21. PubMed ID: 12658736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced XRCC4 association with chromatin DNA analyzed by biochemical fractionation.
    Kamdar RP; Matsumoto Y
    J Radiat Res; 2010; 51(3):303-13. PubMed ID: 20448413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In cellulo phosphorylation of DNA double-strand break repair protein XRCC4 on Ser260 by DNA-PK.
    Amiri Moghani AR; Sharma MK; Matsumoto Y
    J Radiat Res; 2018 Nov; 59(6):700-708. PubMed ID: 30247612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p-DNA-PKcs.
    Li X; Zou S; Zhou L; Gao A; Xu J; He C; Zhou J; Wu S; Chen Y
    Cancer Med; 2022 Oct; 11(20):3809-3819. PubMed ID: 35426246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of DNA double strand break repair and chromosome aberration formation.
    Iliakis G; Wang H; Perrault AR; Boecker W; Rosidi B; Windhofer F; Wu W; Guan J; Terzoudi G; Pantelias G
    Cytogenet Genome Res; 2004; 104(1-4):14-20. PubMed ID: 15162010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
    Ho CK; Kornaga EN; Klimowicz AC; Enwere EK; Dean M; Bebb GD; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
    Gynecol Oncol; 2017 Apr; 145(1):176-184. PubMed ID: 28131528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In cellulo phosphorylation of XRCC4 Ser320 by DNA-PK induced by DNA damage.
    Sharma MK; Imamichi S; Fukuchi M; Samarth RM; Tomita M; Matsumoto Y
    J Radiat Res; 2016 Mar; 57(2):115-20. PubMed ID: 26666690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and results of Ku and XRCC4 expression in hypopharyngeal cancer tissues treated with chemoradiotherapy.
    Hayashi J; Sakata KI; Someya M; Matsumoto Y; Satoh M; Nakata K; Hori M; Takagi M; Kondoh A; Himi T; Hareyama M
    Oncol Lett; 2012 Jul; 4(1):151-155. PubMed ID: 22807979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV.
    Kuhfittig-Kulle S; Feldmann E; Odersky A; Kuliczkowska A; Goedecke W; Eggert A; Pfeiffer P
    Mutagenesis; 2007 May; 22(3):217-33. PubMed ID: 17347130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and clinical significance of DNA-PKcs in nasopharyngeal carcinoma].
    Yan SS; Liu L; Liu ZG; Zeng MS; Song LB; Xia YF
    Ai Zheng; 2008 Sep; 27(9):979-83. PubMed ID: 18799040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished or inversed dose-rate effect on clonogenic ability in Ku-deficient rodent cells.
    Tsuchiya H; Shimada M; Tsukada K; Meng Q; Kobayashi J; Matsumoto Y
    J Radiat Res; 2021 Mar; 62(2):198-205. PubMed ID: 33372229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, localization and focus formation at DNA damage sites of canine XRCC4.
    Koike M; Yutoku Y; Koike A
    J Vet Med Sci; 2017 Jan; 78(12):1865-1871. PubMed ID: 27644316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP1 promotes assembly of non-homologous end joining protein complexes on DNA.
    Heo J; Li J; Summerlin M; Hays A; Katyal S; McKinnon PJ; Nitiss KC; Nitiss JL; Hanakahi LA
    DNA Repair (Amst); 2015 Jun; 30():28-37. PubMed ID: 25841101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer.
    Pavón MA; Parreño M; León X; Sancho FJ; Céspedes MV; Casanova I; Lopez-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Int J Cancer; 2008 Sep; 123(5):1068-79. PubMed ID: 18546291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In normal human fibroblasts variation in DSB repair capacity cannot be ascribed to radiation-induced changes in the localisation, expression or activity of major NHEJ proteins.
    Kasten-Pisula U; Vronskaja S; Overgaard J; Dikomey E
    Radiother Oncol; 2008 Mar; 86(3):321-8. PubMed ID: 18158193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.